Document Preview Unavailable
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro
You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library